Real-world evidence
Caporusso et al case series1
In real-world patients (retrospective case series), NuShield® was used as a covering in a wide variety of wounds (N=50), including VLUs (n=14), DFUs (n=24), and other wounds (pressure ulcers, nonhealing surgical, ischemic, mixed etiology, and nonhealing amputation; n=12).1
DFU=diabetic foot ulcer; VLU=venous leg ulcerMedian time to wound closure1


Percentage of wounds closed by week1


Of those wounds that did not achieve wound closure, 9 (18%) had >90% wound closure, and 8 (16%) had wound closures ranging from 60% to 90% by the last observation.1
Composition comparison for NuShield
See the results comparing NuShield to another commercially available dHACM, or talk to an Organogenesis Tissue Regeneration Specialist about the dehydrated placental allograft wound covering that retains all native layers.
Contact usNuShield is intended to be used as a wound covering and barrier.
Please refer to the NuShield instructions for use for usage and safety information.
REFERENCE:
- Caporusso J, et al. Wounds. 2019;31(4 Suppl):S19-S27.